Skip to main content

Table 2 Available applicators for use in children and adolescents

From: Regional hyperthermia combined with chemotherapy in paediatric, adolescent and young adult patients: current and future perspectives

Available applicators with dimensions, treatable craniocaudal tumour length and permitted maximal lateral and dorsoventral dimensions of the patient

 

Sigma 30

Sigma 40

Sigma Eye

Applicator length (bolus)

25

40

50

Applicator internal diameter (bolus)

27x27

42

54 x 37

Approximate maximal craniocaudal tumour length

~15–20

~25–30

~35–40

Maximal lateral (x) and dorsoventral (y) patient dimensions (pelvis/abdomen)

x ≤ 19 cm

y ≤ 19 cm

19 cm < x ≤ 34 cm

19 cm < y ≤ 34 cm

19 cm < x ≤ 44 cm

19 cm < y ≤ 29 cm